On October 3, 2025, LifeVantage Corporation announced the closing of its acquisition of LoveBiome, a direct‑sales company focused on microbiome care. The transaction completed the purchase of LoveBiome’s critical operating assets and retained key personnel, solidifying the integration of the two businesses.
The deal expands LifeVantage’s product portfolio into the rapidly growing gut‑health market by adding LoveBiome’s P84 microbiome product. It also broadens the company’s geographic reach to the United States, Taiwan, and Europe, positioning LifeVantage to serve a wider customer base.
By combining LoveBiome’s microbiome solutions with LifeVantage’s Activation technologies and compensation plan, the company can cross‑sell products, potentially increasing revenue streams and customer engagement. The retention of LoveBiome staff ensures continuity and facilitates a smooth integration of operations.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.